228 related articles for article (PubMed ID: 20957082)
1. Identification of tetranectin as a potential biomarker for metastatic oral cancer.
Arellano-Garcia ME; Li R; Liu X; Xie Y; Yan X; Loo JA; Hu S
Int J Mol Sci; 2010 Sep; 11(9):3106-21. PubMed ID: 20957082
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potential serum protein biomarkers for lymph node metastasis in oral cancer.
Chai YD; Zhang L; Yang Y; Su T; Charugundla P; Ai J; Messadi D; Wong DT; Hu S
Head Neck; 2016 Jan; 38(1):118-25. PubMed ID: 25223295
[TBL] [Abstract][Full Text] [Related]
4. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.
Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC
Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657
[TBL] [Abstract][Full Text] [Related]
5. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
6. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches.
Heawchaiyaphum C; Pientong C; Phusingha P; Vatanasapt P; Promthet S; Daduang J; Teeramatwanich W; Kongyingyoes B; Chuerduangphui J; Ekalaksananan T
J Proteomics; 2018 Feb; 173():52-61. PubMed ID: 29199150
[TBL] [Abstract][Full Text] [Related]
7. Salivary proteomics for oral cancer biomarker discovery.
Hu S; Arellano M; Boontheung P; Wang J; Zhou H; Jiang J; Elashoff D; Wei R; Loo JA; Wong DT
Clin Cancer Res; 2008 Oct; 14(19):6246-52. PubMed ID: 18829504
[TBL] [Abstract][Full Text] [Related]
8. Discovery and preclinical validation of proteomic biomarkers in saliva for early detection of oral squamous cell carcinomas.
Shan J; Sun Z; Yang J; Xu J; Shi W; Wu Y; Fan Y; Li H
Oral Dis; 2019 Jan; 25(1):97-107. PubMed ID: 30169911
[TBL] [Abstract][Full Text] [Related]
9. A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva.
Kawahara R; Bollinger JG; Rivera C; Ribeiro AC; Brandão TB; Paes Leme AF; MacCoss MJ
Proteomics; 2016 Jan; 16(1):159-73. PubMed ID: 26552850
[TBL] [Abstract][Full Text] [Related]
10. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
11. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
[TBL] [Abstract][Full Text] [Related]
12. Oral Health May Affect the Performance of mRNA-Based Saliva Biomarkers for Oral Squamous Cell Cancer.
Horváth J; Szabó A; Tar I; Dezső B; Kiss C; Márton I; Scholtz B
Pathol Oncol Res; 2018 Oct; 24(4):833-842. PubMed ID: 28861772
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
15. Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.
Hsu CW; Yu JS; Peng PH; Liu SC; Chang YS; Chang KP; Wu CC
J Proteome Res; 2014 Nov; 13(11):4796-807. PubMed ID: 24708169
[TBL] [Abstract][Full Text] [Related]
16. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
Jiang T; Liu G; Wang L; Liu H
PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
[TBL] [Abstract][Full Text] [Related]
17. Potential biomarkers for oral squamous cell carcinoma: proteomics discovery and clinical validation.
Ni YH; Ding L; Hu QG; Hua ZC
Proteomics Clin Appl; 2015 Feb; 9(1-2):86-97. PubMed ID: 25431113
[TBL] [Abstract][Full Text] [Related]
18. Serum HSP90-Alpha and Oral Squamous Cell Carcinoma: A Prospective Biomarker.
Usman M; Ilyas A; Syed B; Hashim Z; Ahmed A; Zarina S
Protein Pept Lett; 2021; 28(10):1157-1163. PubMed ID: 34137356
[TBL] [Abstract][Full Text] [Related]
19. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
20. Identification of salivary autoantibodies as biomarkers of oral cancer with immunoglobulin A enrichment combined with affinity mass spectrometry.
Chu HW; Chang KP; Yen WC; Liu HP; Chan XY; Liu CR; Hung CM; Wu CC
Proteomics; 2023 May; 23(9):e2200321. PubMed ID: 36625099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]